Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreren
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

BIOCRYST PHARMACEUTICALS, INC.

(BCRX)
  Rapport
Vertraagde tijd Nasdaq  -  22:00:00 07-02-2023
10.68 USD   +0.38%
26/01BioCryst Pharmaceuticals neemt eerste patiënt op in pediatrisch onderzoek naar erfelijk angio-oedeem
MT
26/01BioCryst begint met de inschrijving voor de cruciale APeX-P-studie ter evaluatie van Orladeyo(R) (Berotralstat) bij pediatrische patiënten met erfelijk angio-oedeem.
CI
23/01BioCryst Pharmaceuticals tekent overeenkomst met Swixx BioPharma om Orladeyo in Centraal- en Oost-Europa op de markt te brengen.
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
ETF's gepositioneerd op BIOCRYST PHARMACEUTICALS, INC.ETF's en trackers met Trackinsight
ETF gewichtVariatie 5 dagenRatingGeografie
ETFMG Treatments Testing and Advancements E...2.95%1.65%-NC
Virtus LifeSci Biotech Products ETF - USD1.98%2.04%VS
ALPS Medical Breakthroughs ETF - USD1.23%2.19%VS
SPDR S&P Biotech ETF - USD1.02%1.12%VS
Global X S&P Biotech ETF - AUD1.02%4.00%-VS
First Trust Small Cap Growth AlphaDEX Fund - USD0.44%2.95%NC
Principal U.S. Small-Cap Multi-Factor ETF - USD0.32%3.73%VS
Xtrackers MSCI Genomic Healthcare Innovatio...0.3%1.56%-NC
IShares Nasdaq US Biotechnology - USD0.24%0.72%VS
IShares Nasdaq US Biotechnology (D) - USD0.24%0.78%VS
Invesco Nasdaq Biotechnology ETF - USD0.24%-1.00%-VS
IShares Biotechnology ETF - USD0.23%0.60%-NC
BMO MSCI Genomic Innovation Index ETF - CAD0.22%1.73%-NC
IShares Morningstar Small-Cap Growth ETF - USD0.15%4.12%-NC
Vanguard Russell 2000 Growth ETF - USD0.14%3.70%VS
IShares Russell 2000 Growth ETF - USD0.14%3.76%VS
CSIF (IE) MSCI USA Small Cap ESG Leaders Bl...0.13%3.37%-VS
Vanguard Russell 2000 ETF - USD0.1%3.82%VS
Xtrackers Russell 2000 1C - USD0.1%3.64%VS
IShares Russell 2000 ETF - USD0.1%3.91%VS
First Trust Multi Cap Growth AlphaDEX Fund - USD0.09%1.68%VS
First Trust Small Cap Core AlphaDEX Fund - USD0.08%3.70%VS
Schwab U.S. Small-Cap ETF - USD0.08%3.82%VS
IShares Russell 2000 Value ETF - USD0.07%4.23%VS
IShares Morningstar Small-Cap ETF - USD0.07%3.90%-NC
Vanguard Russell 2000 Value ETF - USD0.07%4.13%VS
Vanguard Small-Cap Growth ETF - USD0.07%3.52%VS
Goldman Sachs ActiveBeta U.S. Small Cap Equ...0.06%3.75%VS
Vanguard Extended Market ETF - USD0.04%3.44%VS
Fidelity MSCI Health Care Index ETF - USD0.04%0.41%VS
Vanguard MSCI International Small Companies...0.04%4.49%-Wereld
Vanguard Health Care ETF - USD0.04%0.49%VS
Vanguard Small Cap ETF - USD0.03%3.44%VS
Fidelity NASDAQ Composite Index ETF - USD0.02%4.32%-VS
IShares Core S&P Total U.S. Stock Market ETF - USD0.01%2.53%VS
Vanguard Russell 3000 ETF - USD0.01%2.54%VS
IShares Russell 3000 ETF - USD0.01%2.53%VS
Vanguard Total Stock Market ETF - USD0.01%2.52%VS
Vanguard FTSE Global All Cap ex Canada Inde...0%1.48%Wereld
IShares Core MSCI All Country World ex Cana...0%1.17%-Wereld



Copyright © 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (ďInformationĒ) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Grafiek BIOCRYST PHARMACEUTICALS, INC.
Duur : Periode :
BioCryst Pharmaceuticals, Inc. : Grafische technische analyse BioCryst Pharmaceuticals, Inc. | MarketScreener
Grafiek op volledig scherm
Evolutie van de resultatenrekening
Consensus
Verkoop
Koop
Gemiddeld advies Accumuleren
Aantal analisten 12
Laatste slotkoers 10,64 $
Gemiddelde koersdoel 16,70 $
Spread / Gemiddelde doel 57,0%
Grafiek BIOCRYST PHARMACEUTICALS, INC.
Duur : Periode :
BioCryst Pharmaceuticals, Inc. : Grafische technische analyse BioCryst Pharmaceuticals, Inc. | MarketScreener
Grafiek op volledig scherm
Sector en concurrentie
Verschil t.o.v. 1 jan (%)Kapitalisatie (M$)
BIOCRYST PHARMACEUTICALS, INC.-7.32%1 984
REGENERON PHARMACEUTICALS, INC.8.54%83 397
VERTEX PHARMACEUTICALS4.24%78 258
WUXI APPTEC CO., LTD.13.21%39 435
BIONTECH SE-5.43%34 256
BEIGENE, LTD.11.48%25 531